Knight Therapeutics Inc. (TSX:GUD)
Canada · Delayed Price · Currency is CAD 9.87
-0.03 (-0.30%)
Sep 10, 2026, 12:49 PM EST
Knight Therapeutics Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 972 | 601 | 536 | 541 | 584 | 630 | |
Market Cap Growth | 51.30% | 12.16% | -0.95% | -7.35% | -7.29% | -9.50% |
Enterprise Value | 886 | 589 | 418 | 455 | 466 | 510 |
Last Close Price | 9.90 | 6.05 | 5.34 | 5.19 | 5.18 | 5.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 65.99 | - | 123.63 | - | - | 40.16 |
Forward PE | 90.00 | 201.67 | 157.06 | 79.24 | 95.37 | 82.43 |
PS Ratio | 1.78 | 1.34 | 1.44 | 1.65 | 1.99 | 2.59 |
PB Ratio | 1.22 | 0.78 | 0.67 | 0.72 | 0.71 | 0.75 |
P/TBV Ratio | 2.74 | 2.02 | 1.26 | 1.43 | 1.44 | 1.51 |
P/FCF Ratio | 8.81 | 8.96 | 15.84 | 15.45 | 13.86 | 15.44 |
P/OCF Ratio | 8.44 | 8.71 | 14.76 | 15.05 | 12.97 | 14.11 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.62 | 1.31 | 1.13 | 1.39 | 1.59 | 2.10 |
EV/EBITDA Ratio | 10.42 | 11.92 | 7.46 | 8.55 | 11.38 | 15.73 |
EV/EBIT Ratio | 40.38 | - | 56.47 | 71.47 | - | - |
EV/FCF Ratio | 8.02 | 8.78 | 12.35 | 13.01 | 11.07 | 12.52 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.10 | 0.06 | 0.09 | 0.09 | 0.05 |
Debt / EBITDA Ratio | 0.40 | 1.46 | 0.83 | 1.24 | 1.73 | 1.18 |
Debt / FCF Ratio | 0.31 | 1.16 | 1.46 | 1.98 | 1.85 | 1.00 |
Net Debt / Equity Ratio | -0.11 | -0.05 | -0.15 | -0.14 | -0.15 | -0.14 |
Net Debt / EBITDA Ratio | -1.07 | -0.73 | -2.20 | -2.03 | -3.00 | -3.67 |
Net Debt / FCF Ratio | -0.79 | -0.54 | -3.65 | -3.09 | -2.92 | -2.92 |
Asset Turnover | 0.53 | 0.45 | 0.39 | 0.33 | 0.29 | 0.24 |
Inventory Turnover | 1.97 | 2.10 | 2.02 | 1.91 | 1.89 | 1.99 |
Quick Ratio | 1.45 | 1.53 | 2.57 | 2.35 | 2.08 | 2.16 |
Current Ratio | 2.28 | 2.39 | 3.57 | 3.20 | 2.80 | 2.90 |
Return on Equity (ROE) | 1.91% | -0.69% | 0.56% | -2.14% | -3.58% | 1.81% |
Return on Assets (ROA) | 1.32% | -0.15% | 0.48% | 0.40% | -1.04% | -0.79% |
Return on Invested Capital (ROIC) | 2.14% | -0.34% | 1.12% | 0.93% | -2.37% | -2.04% |
Return on Capital Employed (ROCE) | 2.50% | -0.30% | 0.90% | 0.80% | -1.90% | -1.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.53% | -0.90% | 0.81% | -3.11% | -5.12% | 2.49% |
FCF Yield | 11.35% | 11.16% | 6.31% | 6.47% | 7.22% | 6.48% |
Buyback Yield / Dilution | 1.29% | 1.84% | 5.61% | 6.46% | 7.74% | 5.66% |